Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/442
Tipo de documento
ArtigoDireito Autoral
Acesso aberto
Objetivos de Desenvolvimento Sustentável
03 Saúde e Bem-EstarColeções
Metadata
Mostrar registro completo
INDUSTRIAL BIOTECHNOLOGY IN PUBLIC HEALTH: PERSPECTIVES FOR LATIN AMERICA AND THE CARIBBEAN
Biotechnology in Public Health
Latin America
Caribbean
Afiliação
Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Department of Virology. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation
Oswaldo Cruz Foundation
Resumo em Inglês
This paper analyzes, by outlining public perspectives, the current industrial biotechnological capacity of Latin America and the Caribbean to develop regional programs for therapeutic drugs, vaccines and
diagnostic products. After discussing perspectives of and constraints on the development of modern industrial biotechnology, the paper concludes by suggesting that, in the face of growing privatization, international negotiations should be redirected. Otherwise, biotechnology will never be a primary resource in the developing world especially in Latin America and the Caribbean
Palavras-chave em inglês
Biotechnology-based productsBiotechnology in Public Health
Latin America
Caribbean
Compartilhar